NEW YORK – With the launch of its first product, a rule-out test for pancreatic cysts that can help risk-stratify patients who may have pancreatic cancer, Purdue University spinout Amplified Sciences ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
A study led by NYU Langone Health researchers sheds light on how the major cancer gene BRCA2 determines which cancer cells ...
The Healthy @Reader's Digest on MSN4d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily ExerciseA woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
News Medical on MSN3d
Study sheds light on how major cancer gene influences the success of PARP inhibitorsA study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
As medical imaging technologies continue to evolve, AI-driven solutions like ARDL play a pivotal role in transforming radiology and enhancing diagnostic confidence.
You are more likely to hear about equine sarcoids and melanomas, horses can develop other types of cancer as well.
A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a ...
What's been going on in the life sciences world? Check out Week in Brief for an overview of the biggest news from the last ...
The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback